Literature DB >> 16185370

Determinants of patient adherence to an aerosol regimen.

Joseph L Rau1.   

Abstract

Patient adherence with prescribed inhaled therapy is related to morbidity and mortality. The terms "compliance" and "adherence" are used in the literature to describe agreement between prescribed medication and patient practice, with "adherence" implying active patient participation. Patient adherence with inhaled medication can be perfect, good, adequate, poor, or nonexistent, although criteria for such levels are not standardized and may vary from one study to another. Generally, nonadherence can be classified into unintentional (not understood) or intentional (understood but not followed). Failing to understand correct use of an inhaler exemplifies unintentional nonadherence, while refusing to take medication for fear of adverse effects constitutes intentional nonadherence. There are various measures of adherence, including biochemical monitoring of subjects, electronic or mechanical device monitors, direct observation of patients, medical/pharmacy records, counting remaining doses, clinician judgment, and patient self-report or diaries. The methods cited are in order of more to less objective, although even electronic monitoring can be prone to patient deception. Adherence is notoriously higher when determined by patient self-report, compared to electronic monitors. A general lack of adherence with inhaled medications has been documented in studies, and adherence declines over time, even with return clinic visits. Lack of correct aerosol-device use is a particular type of nonadherence, and clinician knowledge of correct use has been shown to be imperfect. Other factors related to patient adherence include the complexity of the inhalation regimen (dosing frequency, number of drugs), route of administration (oral vs inhaled), type of inhaled agent (corticosteroid adherence is worse than with short-acting beta2 agonists), patient awareness of monitoring, as well as a variety of patient beliefs and sociocultural and psychological factors. Good communication skills among clinicians and patient education about inhaled medications are central to improving adherence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185370

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  26 in total

1.  Virtual Teach-To-Goal™ Adaptive Learning of Inhaler Technique for Inpatients with Asthma or COPD.

Authors:  Valerie G Press; Colleen A Kelly; John J Kim; Steven R White; David O Meltzer; Vineet M Arora
Journal:  J Allergy Clin Immunol Pract       Date:  2017-01-05

2.  Optimizing the language and format of guidelines to improve guideline uptake.

Authors:  Samir Gupta; Navjot Rai; Onil Bhattacharrya; Alice Y Y Cheng; Kim A Connelly; Louis-Philippe Boulet; Alan Kaplan; Melissa C Brouwers; Monika Kastner
Journal:  CMAJ       Date:  2016-04-18       Impact factor: 8.262

3.  A nurse-led intervention study: Promoting compliance with Diskus Inhaler use in asthma patients.

Authors:  Elaine Mac Hale; Richard W Costello; Seamus Cowman
Journal:  Nurs Open       Date:  2014-11-28

Review 4.  Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.

Authors:  Ali Keshavarz; Hossam Kadry; Ahmed Alobaida; Fakhrul Ahsan
Journal:  Expert Opin Drug Deliv       Date:  2020-02-19       Impact factor: 6.648

5.  Asthma beliefs are associated with medication adherence in older asthmatics.

Authors:  Anastasia Sofianou; Melissa Martynenko; Michael S Wolf; Juan P Wisnivesky; Katherine Krauskopf; Elizabeth A H Wilson; Mita Sanghavi Goel; Howard Leventhal; Ethan A Halm; Alex D Federman
Journal:  J Gen Intern Med       Date:  2012-08-10       Impact factor: 5.128

6.  Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence.

Authors:  Francesco Patti
Journal:  Patient Prefer Adherence       Date:  2010-02-04       Impact factor: 2.711

7.  Measurement of inhaled corticosteroid adherence in inner-city, minority children with persistent asthma by parental report and integrated dose counter.

Authors:  Marina Reznik; Philip O Ozuah
Journal:  J Allergy (Cairo)       Date:  2012-03-15

8.  The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial.

Authors:  Kris Vanhaecht; Walter Sermeus; Jan Peers; Cathy Lodewijckx; Svin Deneckere; Fabrizio Leigheb; Marc Decramer; Massimiliano Panella
Journal:  Trials       Date:  2010-11-19       Impact factor: 2.279

Review 9.  How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze.

Authors:  Wim M van Aalderen; Luis Garcia-Marcos; Monika Gappa; Warren Lenney; Søren Pedersen; Richard Dekhuijzen; David Price
Journal:  NPJ Prim Care Respir Med       Date:  2015-01-08       Impact factor: 2.871

10.  Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma.

Authors:  Kai-Michael Beeh; Craig LaForce; Martina Gahlemann; Arne Wenz; Robert Toorawa; Matjaž Fležar
Journal:  Respir Res       Date:  2015-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.